Fundraising Fox

Biotech Series B Investors & VC Firms

900 firms in this list, with a median first check of $550K. 188 of them lead rounds. Generated from verified public data and updated continuously.

Sonder Capital
San CarlosPre-Seed–Late Stage
15 people
LYFE Capital
Menlo ParkSeed–Late Stage
17 people
New Science Ventures
GreenwichSeed–Late Stage$2M – $8M
7 people
Brightlands Venture Partners
GeleenSeed–Series B$540K – $2.2M
15 people
CTI Life Sciences Fund L.P.
MontréalSeed–Late Stage
9 people
White Fund
LiègeSeed–Series B$2.2M – $5.4M
15 people
Cowin Capital Group
ShenzhenSeed–Late Stage$1.4M – $50M
11 people
Waseda University Ventures
TokyoPre-Seed–Growth
8 people
America's Frontier Fund
ArlingtonPre-Seed–Growth$500K – $10M
13 people
Debiopharm Innovation Fund
LausannePre-Seed–Late Stage$1M – $5M
13 people
IDG Capital Vietnam
HanoiSeed–Late Stage$250K – $3M
13 people
Side Door Ventures
Fernandina BeachPre-Seed–Growth$300K – $5M
16 people
Co-Win Ventures
SuzhouSeed–Series B
Enterprise Investors Sp. z o. o.
WarsawSeries A–Growth$21.6M – $81M
24 people
Grazia Equity GmbH
StuttgartSeed–Late Stage$540K – $2.7M
8 people
Kobe University Capital
KobePre-Seed–Growth
10 people
DNA Capital
São PauloPre-Seed–Late Stage$100K – $5M
15 people
Senovo
MunichSeed–Late Stage$1.1M – $5.4M
6 people
Xeraya Capital
Kuala LumpurSeed–Growth
20 people
Visionary Ventures
Newport BeachSeries A–Late Stage$5M – $15M
13 people
Foreground Capital
BostonPre-Seed–Series B
9 people
LBBW Venture Capital GmbH
StuttgartSeed–Late Stage$540K – $3.2M
9 people
Marathon Venture Capital
AthensSeed–Series B$250K – $1M
6 people
Breakthrough Victoria
MelbournePre-Seed–Late Stage
11 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.